Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

15.2K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.2K
Cancer02:18

Cancer

55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Mutations01:35

Mutations

45.0K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
45.0K
Mutations01:39

Mutations

95.4K
Overview
95.4K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

6.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety of Post-transplant Cyclophosphamide as a Single Agent for Graft-Versus-Host Disease Prophylaxis After Human Leukocyte Antigen (HLA)-Matched Transplantation With the Japanese Population: A Single-Center Phase Ⅰ/Ⅱ Study.

Cureus·2026
Same author

Tracking of Donor Erythropoiesis following ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation.

Transplantation and cellular therapy·2026
Same author

Tumor necrosis factor from leukemic environment stimulates hematopoietic stem/progenitor cells toward megakaryocyte/myeloid lineage bias.

Experimental hematology·2025
Same author

Recent progress in clonal hematopoiesis: expanding the concept.

International journal of hematology·2025
Same author

Clones in blood and stratified epithelial cells, and their drivers.

Proceedings of the Japan Academy. Series B, Physical and biological sciences·2025
Same author

Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study.

British journal of haematology·2025

Related Experiment Video

Updated: Mar 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K

Gene mutations in malignant lymphoma.

Shigeru Chiba1

  • 1Department of Hematology, Faculty of Medicine, University of Tsukuba.

[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|January 17, 2017
PubMed
Summary
This summary is machine-generated.

Cancer genome research has revealed frequent mutations in mature B-cell and T/NK-cell lymphomas. These mutations in signaling pathways and other genes create unique profiles for each lymphoma type, guiding new drug development.

More Related Videos

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Related Experiment Videos

Last Updated: Mar 8, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

25.2K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.7K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.8K

Area of Science:

  • Genomics
  • Oncology
  • Molecular Biology

Background:

  • Second-generation sequencing has rapidly advanced cancer genome research since 2009.
  • Malignant lymphomas, particularly mature B-cell lymphomas, exhibit frequent genetic mutations.
  • Understanding these mutations is crucial for lymphoma classification and treatment.

Purpose of the Study:

  • To summarize the current understanding of genetic mutations in mature B-cell and T/NK-cell lymphomas.
  • To highlight the characteristic mutation profiles across different lymphoma subtypes.
  • To underscore the implications of these findings for developing targeted therapies.

Main Methods:

  • Analysis of accumulated cancer genome data, primarily from second-generation sequencing.
  • Identification and categorization of frequently mutated genes in lymphoma subtypes.
  • Comparison of mutation frequencies across various lymphoma types.

Main Results:

  • Mature B-cell lymphomas show mutations in signaling pathways (B-cell receptor, Toll-like receptor, NF-κB, NOTCH) and histone modifiers.
  • Mature T/NK-cell lymphomas have mutations in T-cell receptor, NF-κB, DNA methylation regulators, and JAK-STAT pathways.
  • Distinct gene mutation profiles characterize different lymphoma types, despite some shared mutations.

Conclusions:

  • The genetic landscape of lymphomas is complex, with pathway-specific mutations being common.
  • Characteristic mutation profiles offer insights into lymphoma pathogenesis.
  • This knowledge forms a foundation for developing novel molecular-targeted drugs for lymphomas.